|Bid||34.24 x 1300|
|Ask||34.25 x 800|
|Day's Range||33.87 - 34.70|
|52 Week Range||31.43 - 48.25|
|Beta (5Y Monthly)||0.34|
|PE Ratio (TTM)||34.45|
|Earnings Date||Feb 01, 2017 - Feb 06, 2017|
|Forward Dividend & Yield||1.89 (5.36%)|
|Ex-Dividend Date||May 14, 2020|
|1y Target Est||48.67|
Jefferies Healthcare Equity Strategy Jared Holz joins Yahoo Finance’s Kristin Myers to break down the latest on coronavirus vaccine developments.
Vaccination rates, which fell sharply during the brunt of the coronavirus lockdowns, have mostly returned to pre-pandemic levels, GSK said.
GSK Consumer Healthcare (LSE/NYSE: GSK) today announced the launch of Robitussin® Naturals, the brand's first-ever line of drug-free products that provide relief from occasional cough†*. As the 1 cough relief brand** with more than 70 years of experience treating coughs, Robitussin® knows what it takes to shut a cough down and especially in these trying times, knows that all Americans could use a boost of cheer. To help inspire consumers to take action to shut down their coughs, Robitussin has partnered with Collegiate National Champion Cheer Coach, Monica Aldama.